RCM
Regency Capital Management Portfolio holdings
AUM
$191M
This Quarter Return
+9.83%
1 Year Return
+19.45%
3 Year Return
+62.33%
5 Year Return
–
10 Year Return
–
AUM
$149M
AUM Growth
+$149M
(+26%)
Cap. Flow
+$22.1M
Cap. Flow
% of AUM
14.83%
Top 10 Holdings %
Top 10 Hldgs %
52.74%
Holding
60
New
15
Increased
18
Reduced
13
Closed
9
Top Buys
| 1 |
Vanguard International Dividend Appreciation ETF
VIGI
|
$4.2M |
| 2 |
Veralto
VLTO
|
$4.09M |
| 3 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
$3.84M |
| 4 |
Charles River Laboratories
CRL
|
$3.7M |
| 5 |
Camden Property Trust
CPT
|
$3.58M |
Top Sells
| 1 |
Accenture
ACN
|
$2.32M |
| 2 |
Brookfield
BN
|
$2.23M |
| 3 |
Nutrien
NTR
|
$2.17M |
| 4 |
Chubb
CB
|
$2M |
| 5 |
Cboe Global Markets
CBOE
|
$1.98M |
Sector Composition
| 1 | Healthcare | 16.01% |
| 2 | Industrials | 14.05% |
| 3 | Financials | 13.86% |
| 4 | Technology | 11.73% |
| 5 | Consumer Staples | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Day One Biopharmaceuticals
DAWN
$769M
| $175K | 0.12% |
12,000
| – | – |
|
52
Arcutis Biotherapeutics
ARQT
$1.86B
| – | – |
-13,000
| Closed | -$69K |
|
|
53
Brookfield
BN
$98.3B
| – | – |
-71,206
| Closed | -$2.23M |
|
|
54
Cboe Global Markets
CBOE
$24.7B
| – | – |
-12,665
| Closed | -$1.98M |
|
55
CME Group
CME
$96B
| – | – |
-3,959
| Closed | -$793K |
|
|
CRESY
56
Cresud
CRESY
$615M
| – | – |
-18,571
| Closed | -$124K |
|
57
iShares MSCI South Korea ETF
EWY
$5.13B
| – | – |
-16,346
| Closed | -$963K |
|
58
Illinois Tool Works
ITW
$77.1B
| – | – |
-8,030
| Closed | -$1.85M |
|
|
59
Nutrien
NTR
$28B
| – | – |
-35,113
| Closed | -$2.17M |
|
|
KLRS
60
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
| – | – |
-30,025
| Closed | -$64.6K |
|